Tumor Suppressor miR-34a: Potential Biomarker of TACE Response in HCC
CardioVascular and Interventional Radiology · 2025
DOI: 10.1007/s00270-024-03908-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift CardioVascular and Interventional Radiology, 2025. Verfasst von Jan Zavadil und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology and Nuclear Medicine, University Hospital Brno and Masaryk University Brno, Jihlavská 340/20, 625 00, Brno, Czechia. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, MicroRNAs, Chemoembolization, Therapeutic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Masarykova Univerzita, Ministerstvo Zdravotnictví Ceské Republiky, Vysoká Škola Bánská - Technická Univerzita Ostrava.
Abstract (Originalsprache)
PURPOSE: TACE induces variable systemic effects by producing factors that promote inflammation, oncogenesis, and angiogenesis. Here we compare concentrations of microRNAs (miR-21, miR-210 and miR-34a) and vascular endothelial growth factor (VEGF) in hepatocellular carcinoma (HCC) patients undergoing TACE with degradable (DSM) and nondegradable (DEB) particles and potential use of these biomarker changes for prediction of patient outcomes. MATERIALS AND METHODS: Overall, 52 patients with HCC treated with DSM TACE (24 patients) and DEB TACE (28 patients) were included in this prospective study. Concentrations of studied biomarkers were measured from blood plasma preprocedurally, immediately (< 90 min) postprocedurally, and 24-h after TACE. Levels were compared between DSM and DEB TACE and correlated with treatment response six and 12 months after the first TACE. RESULTS: Both DSM and DEB TACE elevated plasma levels of miR-21, miR-34a, and miR-210 at 24 h post-procedure compared to baseline levels (FC 1.25-4.0). MiR-34a elevation immediately after TACE was significantly associated with nonprogressive disease compared to those with progressive disease at both six months (FCa: p = 0.014) and 12 months (FCa: p = 0.029) post-TACE. No significant biomarker changes were found between the embolization particle groups. However, VEGF levels showed a decrease only in the DSM TACE group (FC24: p = < 0.001). CONCLUSION: Embolization particle type did not significantly impact miRNA or VEGF changes post-TACE. However, miR-34a elevation immediately after the procedure predicts better patient outcome and may prove useful as a biomarkers for the monitoring of clinical outcomes. LEVEL OF EVIDENCE: Level 3 Prospective cohort study.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology and Nuclear Medicine, University Hospital Brno and Masaryk University Brno, Jihlavská 340/20, 625 00, Brno, Czechia.
- Central European Institute of Technology, Kamenice 753/5, 625 00, Brno, Czechia.
- CERIT-SC Centre, Institute of Computer Science, Masaryk University, Šumavská 416/15, 602 00, Brno, Czechia.
- Department of Applied Mathematics, Faculty of Electrical Engineering and Computer Science, VSB-Technical University of Ostrava, 17. Listopadu 2172/15, 708 00, Ostrava, Czechia.
- Masaryk Memorial Cancer Institute, Žlutý Kopec 543/7, 602 00, Brno, Czechia.
- Hadassah Hebrew University Medical Center, Ein Karem, Jerusalem, Israel.
Förderung
- Masarykova Univerzita
- Ministerstvo Zdravotnictví Ceské Republiky
- Vysoká Škola Bánská - Technická Univerzita Ostrava
Zitieren
APA
Zavadil, J., Juracek, J., Cechova, B., Rohan, T., Husty, J., Slaby, O., Litschmannova, M., Uher, M., Goldberg, S. N., & Andrasina, T. (2025). Tumor Suppressor miR-34a: Potential Biomarker of TACE Response in HCC. CardioVascular and Interventional Radiology. https://doi.org/10.1007/s00270-024-03908-5
Vancouver
Zavadil J, Juracek J, Cechova B, Rohan T, Husty J, Slaby O, et al. Tumor Suppressor miR-34a: Potential Biomarker of TACE Response in HCC. CardioVascular and Interventional Radiology. 2025. doi:10.1007/s00270-024-03908-5
BibTeX
@article{Zavadil2025,
author = {Zavadil, Jan and Juracek, Jaroslav and Cechova, Barbora and Rohan, Tomas and Husty, Jakub and Slaby, Ondrej and Litschmannova, Martina and Uher, Michal and Goldberg, S Nahum and Andrasina, Tomas},
title = {Tumor Suppressor miR-34a: Potential Biomarker of TACE Response in HCC},
journal = {CardioVascular and Interventional Radiology},
year = {2025},
doi = {10.1007/s00270-024-03908-5}
}
EUVIMED